Allergan plc, has received approval from the U.S. Food and Drug Administration (FDA) to market ACZONE® (dapsone) Gel, 7.5%, a new prescription  opical treatment for acne in patients 12 years of age and older. ACZONE® Gel, 7.5%

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In